Posted on

CareDx Unveils New Patient-Centered Medication Management Features on AlloCare Mobile Health App

Loading

Integration of MedActionPlan PRO Facilitates Patient-Clinician Interaction to Improve Medication Adherence

BRISBANE, Calif.–(BUSINESS WIRE)– CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that its AlloCare® mobile health app features expanded medication adherence and patient-provider communication capabilities resulting from the successful integration of MedActionPlan®, an acquisition made last year. Read the full press release on CareDx.com.

Loading
Posted on

CareDx Lead Sponsor for 2022 Donate Life Transplant Games

Loading

CareDx’s Mobile Health App, AlloCare, is the Official App for the Games

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Jun. 28, 2022– CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced its participation and presenting sponsorship for the 2022 Donate Life Transplant Games taking place July 29 to August 3, 2022, in San Diego, California. CareDx’s transplant patient health app, AlloCare®, is the official app for the Games. Read the full press release here.

Loading
Posted on

President of TRIO Discusses Transplantation Experience in Time of COVID-19

Loading

“Jim Gleason, National President of Transplant Recipients International Organization (TRIO), discusses what organ transplant patients are experiencing during the pandemic, and some tips they ought to consider to help ease some of the burden.

Mr. Gleason also discusses his role in the development of the recently released AlloCare app is in the AppStore, to help post-transplant recipients navigate their day-to-day health.”

Read the full interview here.

Loading